What changed from existing technology?
This study looked at how the nerves under the cornea and the feeling in the eye change after a special treatment for people with damaged eye surfaces. The treatment uses the patient's own cells to rebuild the eye's surface. The study found that even though the nerves were missing, the feeling in the eye was still normal.
This study is the first to examine both corneal sub-basal nerve status and corneal sensation together after cultivated limbal epithelial transplantation, revealing a structural-functional dissociation that was previously unknown.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 2
long-term (35–56 months) outcomes of five consecutive patients with limbal stem cell deficiency treated with Nepic®, Japan’s insurance-reimbursed autologous
Abstract ↗corneal nerve fibre density 0), yet corneal sensation remained within or close to the normal range in all Nepic®-only eyes, indicating a structural–funct
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This finding suggests that corneal sensation may not always correlate with sub-basal nerve status, which could influence clinical assessments and treatment strategies for corneal conditions.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.